“We still don’t have a full, complete understanding of stimulant use on the ground. There seem to be all kinds of mixed messages flying around,” said Kendra Viner, the opioid surveillance program manager for Philadelphia’s Public Health Department. “There definitely seems to be a disconnect between what people think they’re buying and what’s found in their toxicology if they die, or their drugs are tested. There are a lot of really dangerous cutting agents on the scene.”
By Aubrey Whelan
A $150 million, 300,000-square-foot mixed-use development is planned for 500 S. Broad St., where Philadelphia’s premier public sexual-health clinic once operated.
By Jake Blumgart
An estimated 9,928 patients used the District Health Center No. 1 through the first six months of this year before the services were moved, according to the city’s Department of Health.
By Mike D’Onofrio